Enlarge / A critical care nurse assists a patient. (credit: Getty | Katherine Frey/The Washington Post )

More than 2,800 people may be working as nurses under false pretenses after allegedly buying a fake diploma for between $10,000 and $15,000 from a massive Florida-based scheme recently busted by federal investigators. State and federal authorities are now working to track down the alleged fraudulent nurses, and in some cases, immediately annulling their licenses.

Last week, the Department of Justice announced charges against 25 people in five states connected to the alleged scheme . The investigation, code-named Operation Nightingale, found evidence that the 25 defendants worked to sell more than 7,600 fake diplomas, along with transcripts, between 2016 and 2021, making over $100 million in the process. The fraudulent diplomas and transcripts were allegedly issued from three accredited Florida-based nursing schools: Siena College and Sacred Heart International Institute in Broward County and Palm Beach School of Nursing in Palm Beach County.

The three schools are now closed and the 25 defendants each face up to 20 years in prison.

Stratview Research has published a new report titled ‘Healthcare Cleanroom Consumables Market’ to its database. It has segmented the market By Type (Wipers, Cleanroom Apparels, Cleaning Products, Cleanroom Stationery), By Application (Pharmaceutical, Biotechnology, Medical Devices, Academia, Hospitals), and by Region (North America [The USA, Canada, and Mexico], Europe, and Rest of the World [Brazil, Saudi Arabia, and Others]).

Market Segments' Analysis

The market researchers have studied the Healthcare Cleanroom Consumables Market minutely for better understanding. The report consists of segment-wise details to assist the users in making suitable decisions for better growth opportunities. Below is the short piece of information -

Based on type, the healthcare cleanroom consumables market has been classified into wipers, cleanroom apparels, cleaning products, and cleanroom stationery. The wipers segment accounted for the largest market in 2020. Wipes are widely used in hospitals and cleanrooms for disinfection of the surfaces before and after medical procedures. Also, they can be delivered to room temperature surfaces by being wrapped around a paper tube which has been soaked with wipes solutions, thus bolsters the segment growth.

To Request a Free Sample Click here

Key Players of the market: • Contec (Japan) • DuPont (US) • Kimberly-Clark (US) • KM (US) • Micronclean (UK) • Micronova Manufacturing (US) • Nitritex (UK)

In terms of region, the North America Healthcare Cleanroom Consumables market accounted the highest share in 2020 and is expected to grow at a robust CAGR during the review period. The Healthcare Cleanroom Consumables market growth is mainly attributed to strong presence a properly structured health care sector, well-established healthcare system, large presence of pharmaceutical and biopharmaceutical companies, and high healthcare expenditure.

Highlights of the report:

The report also highlights the following segments -

• The market structure and forecasts for the coming years.
• Drivers, restraints, opportunities, and current trends of Healthcare Cleanroom Consumables Market.
• Historical data and forecast.
• Estimations for the forecast period 2028.
• Developments and trends in the market.

Our market research experts have studied the HEALTHCARE CLEANROOM CONSUMABLES Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-chain, pricing trends, product preferences, consumer patterns & more. The findings are further validated through primary research with industry experts across the globe.

Reasons to Invest in this Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period.
• Segments include quantitative, qualitative, and value data.
• Regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.

Stratview Research has published a new report titled ‘Healthcare Analytics Market’ to its database. It has segmented the market By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), By Component (Hardware, Software, Service) By Application (Financial Analysis, Operational & Administrative Analysis, Clinical Analysis) By End-use (Healthcare Payers, Healthcare Providers, Other), and by Region (North America [The USA, Canada, and Mexico], Europe, and Rest of the World [Brazil, Saudi Arabia, and Others]).

Market Segments' Analysis

The market researchers have studied the Healthcare Analytics Market minutely for better understanding. The report consists of segment-wise details to assist the users in making suitable decisions for better growth opportunities. Below is the short piece of information -

Based on end user, the Healthcare Analytics market has been classified into Healthcare Payers, Healthcare Providers, Other. Healthcare Payers accounted largest segment. This is due to the increasing use of analytical solutions by life science companies to improve product accuracy and efficacy. ToRequest a Free Sample Click here

Key Players of the market: • IBM (US) • Optum (US) • Cerner (US) • SAS Institute (US) • Allscripts (US) • McKesson (US) • MedeAnalytics (US)

In terms of region, the Healthcare Analytics market in North America accounted for the largest market share in 2020. North America's dominance in the healthcare analytics market can be attributed to the implementation of federal health mandates encouraging the adoption of HCIT solutions, an increased focus on PHM, significant VC investments, growing pressure to reduce healthcare costs, technological advancements, and high product and service availability in this region. Furthermore, the majority of the leading players in the healthcare analytics market are headquartered in North America.

Highlights of the report:

The report also highlights the following segments -

• The market structure and forecasts for the coming years.
• Drivers, restraints, opportunities, and current trends of Healthcare Analytics Market.
• Historical data and forecast.
• Estimations for the forecast period 2028.
• Developments and trends in the market.

Our market research experts have studied the HEALTHCARE ANALYTICS Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-chain, pricing trends, product preferences, consumer patterns & more. The findings are further validated through primary research with industry experts across the globe.

Reasons to Invest in this Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period.
• Segments include quantitative, qualitative, and value data.
• Regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.

Enlarge (credit: Getty | SOPA Images )

In his first public remarks since a false tweet inflamed outrage over the cost of insulin in the US, Eli Lilly CEO David Ricks defended his company's pricing—but also conceded it could be lower.

"It probably highlights that we have more work to do to bring down the cost of insulin for more people,” Ricks said of the Twitter fury.

He made his comments at an event held by Stat News this week. Eli Lilly did not respond to Ars' request for more information about what work the company will do to lower prices.

Enlarge

Ben Salentine, associate director of health sciences managed care at the University of Illinois Hospital and Health Sciences System, hasn’t been weighed in more than a decade. His doctors “just kind of guess,” his weight, he said, because they don’t have a wheelchair-accessible scale.

He’s far from alone. Many people with disabilities describe challenges in finding physicians prepared to care for them. “You would assume that medical spaces would be the most accessible places there are, and they're not,” said Angel Miles, a rehabilitation program specialist with the Administration for Community Living, part of the U.S. Department of Health and Human Services.

Not only do clinics often lack the necessary equipment—such as scales that can accommodate people who use wheelchairs — but at least some physicians actively avoid patients with disabilities, using excuses such as “I’m not taking new patients,” or “you need a specialist,” according to a paper in the October 2022 issue of Health Affairs.

Enlarge / Emergency department staff members work at Providence St. Joseph Hospital in Orange, California, on November 1. Orange County's health officer has declared a local health emergency in response to increases in respiratory illnesses and an onslaught of the quickly spreading RSV, a respiratory virus that is most dangerous in young children. (credit: Getty | Orange County Register )

The charge nurse who called 911 last month when her emergency department became overwhelmed with patients is speaking candidly about the chaos, fear, and unsafe conditions that continue to plague her hospital and others around the country .

Kelsay Irby, the ER charge nurse at St. Michael’s Medical Center in the greater Seattle area, penned an eye-opening essay for Nurse.org Tuesday , offering context, commentary, and more details around the infamous night of October 8.

That evening, the hospital's emergency department was "even more short-staffed than normal, operating at less than 50 percent of our ideal staffing grid," Irby said, and there were around 50 people in the waiting room. The nurses were becoming increasingly nervous that some of the people stuck waiting in the lobby had cardiac and respiratory problems, and there were also children with very high fevers. With only one nurse available to keep an eye on people waiting, they could be "unmonitored for extended periods of time."

Enlarge / An isolation tent for an emergency department in Walnut Creek, California, in March 2022. (credit: Getty | Gado )

Although COVID-19 remains in a lull, hospitals across the country are in crisis amid a towering wave of seasonal respiratory illnesses—particularly RSV in children—as well as longer-term problems, such as staffing shortages.

Pediatric beds are filling or full, people with urgent health problems are waiting hours in emergency departments hallways and even parking lots, and some hospitals have pitched outdoor tents, conjuring memories of the early days of the pandemic.

In one of the most striking examples, the emergency department of a Seattle-area hospital became so overwhelmed last month that the department's charge nurse called 911 for help , telling the fire department that they were "drowning" and in "dire straits." There were reportedly over 45 people in the department's waiting room and only five nurses on staff.

Enlarge (credit: Sean Justice/Getty )

Ten years ago, 12-year-old Rory Staunton dove for a ball in gym class and scraped his arm. He woke up the next day with a 104° F fever, so his parents took him to the pediatrician and eventually the emergency room. It was just the stomach flu, they were told. Three days later, Rory died of sepsis after bacteria from the scrape infiltrated his blood and triggered organ failure.

“How does that happen in a modern society?” his father, Ciaran Staunton, said in a recent interview with Undark.

Each year in the United States, sepsis kills over a quarter million people—more than stroke, diabetes, or lung cancer. One reason for all this carnage is that sepsis isn't well understood, and if not detected in time, it’s essentially a death sentence. Consequently, much research has focused on catching sepsis early, but the disease’s complexity has plagued existing clinical support systems—electronic tools that use pop-up alerts to improve patient care—with low accuracy and high rates of false alarm.

Enlarge (credit: Mike Kemp/Getty Images)

At the end of September, a spot of good news: Relyvrio, a new drug for treating amyotrophic lateral sclerosis—or ALS, a neurological disorder without a cure—was approved in the United States. The ALS community rejoiced; the drug’s authorization was described as a “long-sought victory for patients.”

But the next day, the price of the medicine was revealed: $158,000 a year . This was far higher than what the Institute for Clinical and Economic Review, an independent nonprofit that analyzes health care costs, had estimated would be a reasonable price, which it deemed to be between $9,100 and $30,700.